🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Pharmacokinetics, Bioavailability, Safety and Immunogenicity of Single Dose...
Status
Completed
Location
Ppd Development
Start Date
2007-12
Trial ID
NCT00569803
Treatments Being Tested
The purpose of this study is to assess the efficacy, pharmacokinetics, safe...
Status
Completed
Location
Local Institution
Start Date
2009-12
Trial ID
NCT01001832
Treatments Being Tested
The study hypothesis is that SC abatacept is safe and shows evidence of eff...
Status
Completed
Location
Arthritis Associates of Southern California
Start Date
2014-09
Trial ID
NCT02161406
The study is a two-arm, multicenter, double-blinded clinical trial testing ...
Status
Active Not Recruiting
Location
Childrens Hospital of Orange County
Start Date
2023-10-30
Trial ID
NCT03929601
Treatments Being Tested
The purpose of this study is to determine whether a weekly subcutaneous dos...
Status
Completed
Location
Rheumatology Associates, Pc
Start Date
2008-01
Trial ID
NCT00559585
Treatments Being Tested
To evaluate safety and immunogenicity of abatacept when used with or withou...
Status
Completed
Location
Rheumatology Associates Of North Alabama
Start Date
2007-12
Trial ID
NCT00547521
Treatments Being Tested
This is a Phase 2, single center, proof of concept clinical trial in subjec...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2018-11-13
Trial ID
NCT03669861
Treatments Being Tested
The primary objective of this study is to demonstrate superior efficacy of ...
Status
Unknown
Location
Peking union medical college hospital
Start Date
2016-08
Trial ID
NCT02722694
Treatments Being Tested
The objective of the study is to assess the single dose PK, safety, tolerab...
Status
Unknown
Location
Multiple Locations
Start Date
2016-10
Trial ID
NCT02805010
Trial to Evaluate the Efficacy and Safety of Abatacept subcutaneous (SC) in...
Status
Completed
Location
Local Institution - 0015
Start Date
2017-05-04
Trial ID
NCT02971683
Treatments Being Tested